Expression of a core 3 disialyl-Lex hexasaccharide in human colorectal cancers: A potential marker of malignant transformation in colon

Journal of Proteome Research

Volumn 8, Issue 2, 2009, Pages 702-711

  Robbe Masselot, Catherine ^a   Herrmann, Annkatrin ^b   Maes, Emmanuel ^a   Carlstedt, Ingemar ^b   Michalski, Jean Claude ^a   Capon, Calliope ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Clinical samples; Colorectal cancer; Diagnostic marker; Glycosylation; Mass spectrometry; MUC2

Indexed keywords

CARBOHYDRATE; GLYCAN; GLYCOPROTEIN; HEXASACCHARIDE; MUCIN 2; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOOD GROUP ANTIGENS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MUCIN-2; MUCINS; OLIGOSACCHARIDES;

EID: 61849112797     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800740j     Document Type: Article

References (69)

1. Benson, A. B. Epidemiology, disease progression, and economic burden of colorectal cancer. J. Manag. Care Pharm. 2007, 13 (6), S5-18.
2. Byrd, J. C.; Bresalier, R. S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004, 23, 77-99.
3. Hollingsworth, M. A.; Swanson, B. J. Mucins in cancer protection and control of the cell surface. Nat. Rev. Cancer 2004, 4, 45-60.
4. Tytgat, K. M. A. J.; Büller, H. A.; Opdam, F. J. M.; Kim, Y. S.; Einerhand, A. W. C.; Dekker, J. Biosynthesis of human colonic mucin: Muc2 is the predominant secretory mucin. Gastroenterology 1994, 107, 1352-1363.
5. Schwartz, B.; Bresalier, R. S.; Kim, Y. S. The role of mucin in colon cancer metastasis. Int. J. Cancer 1992, 52, 60-65.
6. Sternberg, L. R.; Byrd, J. C.; Yunker, C. K.; Dudas, S.; Hoon, V. K.; Bresalier, R. S. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology 1999, 116, 363-371.
7. Lugli, A.; Zlobec, I.; Baker, K.; Minoo, P.; Tornillo, L.; Terracciano, L.; Jass, J. R. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status. J. Clin. Pathol. 2007, 60, 534-539.
8. Sylvester, P. A.; Myerscough, N.; Warren, B. F.; Carlstedt, I.; Corfield, A. P.; Durdey, P.; Thomas, M. G. Differential expression of the chromosome 11 mucin genes in colorectal cancer. J. Pathol. 2001, 195, 327-335.
9. Blank, M.; Klussmann, E.; Kruger-Krasagakes, S.; Schmitt-Graff, A.; Stolte, M.; Bornhoeft, G.; Stein, H.; Xing, P. X.; McKenzie, I. F.; Verstijnen, C. P. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int. J. Cancer 1994, 59, 301-306.
10. Hanski, C.; Riede, H.; Gratchev, A.; Foss, H. D.; Bohm, C.; Musmann, E.; Hummel, M.; Mann, B.; Buhr, H. J.; Stein, H.; Kim, Y. S.; Gum, J.; Riecken, E. O. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab. Invest. 1997, 77, 685-695.
11. Ajioka, Y.; Allison, L. J.; Jass, J. R. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J. Clin. Pathol. 1996, 49, 560-564.
12. Velcich, A.; Yang, W.; Heyer, J.; Fragale, A.; Nicholas, C.; Viani, S.; Kucherlapati, R.; Lipkin, M.; Yang, JC.; Augenlicht, L. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002, 295, 1726-1729.
13. Bresalier, R. S.; Niv, Y.; Byrd, ). C.; Duh, Q. Y.; Toribara, N. W.; Rockwell, R. W.; Dahiya, R.; Kim, Y. S. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J. Clin. Invest. 1991, 87, 1037-45.
14. Hakamori, S. I. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipids metabolism. Cancer Res. 1996, 56, 5309-5318.
15. Kim, Y. J.; Varki, A. Perspective on the significance of altered glycosylation in cancer. Glycoconjugate J. 1997, 14, 569-576.
16. Brockhausen, I. Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Adv. Exp. Med. Biol. 2003, 535, 163-188.
17. Brockhausen, I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 2006, 7, 599-604.
18. b in human normal, fetal, and malignant colonic tissue. Cancer Res. 1991, 45, 4499-4511.
19. Nakamori, S.; Kameyama, M.; Imaoka, S.; Furukawa, H.; Ishikawa, 0.; Saski, Y.; Kabuto, T.; Iwanaga, T.; Matsushita, Y.; Irimura, T. Increased expression of sialyl Lewis X antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993, 53,3632-3637.
20. Itzkowitz, S. H.; Yuan, M.; Montgomery, C. K.; Kjeldsen, T.; Takahashi, H. K.; Bigbee, W. L.; Kim, Y. S. Expression of Tn, Sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989, 49, 197-204.
21. Itzkowitz, S. H. Carbohydrate changes in colon carcinoma. Acta Pathol. Microbiol. Immunol. Scand. 1992, 100, 173-180.
22. Jass, J. R.; Allison, L. J.; Edgar, S. G. Distribution of sialosyl-Tn and Tn antigens within normal and malignant colorectal epithelium. J. Pathol. 1995, 176, 143-149.
23. Capon, C.; Laboisse, C. L.; Wieruszeski, J. M.; Maoret, J. J.; Augeron, C.; Fournet, B. Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E. J. Biol. Chem. 1992, 267, 19248-19257.
24. Capon, C.; Wieruszeski, J. M.; Lemoine, J.; Byrd, J. C.; Lefler, H.; Kim, Y. S. Sulfated Lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin. J. Biol. Chem. 1997, 272, 31957-31968.
25. Robbe, C.; Capon, C.; Coddeville, B.; Michalski, J. C. Diagnostic ions for the rapid analysis by nano-electrospray ionization quadrupole time-of-flight mass spectrometry of O-glycans from human mucins. Rapid Commun. Mass Spectrom. 2004, 18, 412-420.
26. Herrmann, A.; Davies, J. R.; Lindell, G.; Martensson, S.; Packer, N. H.; Swallow, D. M.; Carlstedt, I. Studies on the "insoluble" glycoprotein complex from human colon. Identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J. Biol. Chem. 1999, 274, 15828-15836.
27. Carlson, D. M. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J. Biol. Chem. 1968, 243, 616-626.
28. Kamerling, J. P.; Gerwig, G. J.; Vliegenthart, J. F.; Clamp, J. R. Characterization by gas-liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of permethylsilyl methylglycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem. J. 1975, 151, 491-495.
29. Montreuil, J.; Bouquelet, S.; Debray, H.; Fournet, B.; Spik, G.; Strecker, G. In Carbohydrate Analysis: A Practical Approach; Chaplin, M. F., Kennedy, J. F., Eds.; IRL Press: Oxford, 1986; pp 143-204.
30. Boland, C. R.; Deshmukh, G. D. The carbohydrate composition of mucin in colonic cancer. Gastroenterology 1990, 98, 1170-1177.
31. Domon, B.; Costello, C. E. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconjugate J. 1988, 5, 397-409.
32. Karlsson, N. G.; Karlsson, H.; Hansson, G. C. Sulphated mucin oligosaccharides from porcine small intestine analysed by four- sector tandem mass spectrometry. J. Mass Spectrom. 1996, 31, 560-572.
33. Podolsky, D. K. Oligosaccharide structures of human colonic mucin. J. Biol. Chem. 1985, 260, 8262-8271.
34. Podolsky, D. K. Oligosaccharide structures of isolated human colonic mucin species. J. Biol. Chem. 1985, 260, 15510-15515.
35. a- antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon. Biochem. J. 2001, 358, 657-664.
36. Robbe, C.; Capon, C.; Maes, E.; Rousset, M.; Zweibaum, A.; Zanetta, J. P.; Michalski, J. C. Evidence of Regio-specific Glycosylation in Human intestinal mucins. J. Biol. Chem. 2003, 278, 46337-46348.
37. Robbe, C.; Capon, C.; Coddeville, B.; Michalski, J. C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 2004, 384, 307-316.
38. King, M. I.; Chan, A.; Roe, R.; Warren, B. F.; Dell, A.; Morris, H. R.; Bartolo, C. C.; Durdey, P.; Corfield, A. P. Two different glycosyl-transferase defects that result in GalNAcα-O peptide (Tn) expression. Glycobiology 1994, 4, 267-269.
39. Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1999, 1473, 67-95.
40. Dabelsteen, E. Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol. 1996, 179, 358-369.
41. Dohi, T.; Yuyama, Y.; Natori, Y.; Smith, P. L.; Lowe, J. B.; Oshima, M. Detection of N-acetylgalactosaminyltransferase mRNA which determines expression of Sda blood group carbohydrate structure in human gastrointestinal mucosa and cancer. Int. J. Cancer 1996, 67, 626-631.
42. Morton, J. A.; Pickles, M. M.; Vanhegan, R. I. The Sda antigen in the human kidney and colon. Immunol. Invest. 1988, 17, 217-224.
43. Malagolini, N.; Dall'Olio, F.; Di Stefano, G.; Minni, F.; Marrano, D.; Serafini-Cessi, F. Expression of UDP-GalNAc:NeuAc alpha 2,3Gal beta-R beta l,4(GalNAc to Gal) N-acetylgalactosaminyl-transferase involved in the synthesis of Sda antigen in human large intestine and colorectal carcinomas. Cancer Res. 1989, 49, 6466- 6470.
44. Iwai, T.; Kudo, T.; Kawamoto, R.; Kubota, T.; Togayachi, A.; Hiruma, T.; Okada, T.; Kawamoto, T.; Morozumi, K.; Narimatsu, H. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 4572-4577.
45. Glycosciences Home page, http://www.glycosciences.de/sweetdb/index.php.
46. Experimental SUGABASE WWW-Page, http://www.boc.chem.uu.nl/ sugabase/sugabase.html.
47. GlycoBase Home page, http://glycobase.univ-lillel.fr/base/.
48. Maes, E.; Bonachera, F.; Strecker, G.; Guerardel, Y. SOACS index: an easy NMR-based query for glycan retrieval. Carbohydr. Res. 2008, in press.
49. Kamerling, J. P.; Vliegenthart, J. F. G. High-resolution lH-nuclear magnetic resonance spectroscopy of oligosaccharide-alditols released from mucin-type O-glycoproteins. Biol. Magn. Res. 1992, 10, 1-288.
50. Capon, C.; Leroy, Y; Wieruszeski, J. M.; Ricart, G.; Strecker, G.; Montreuil, J.; Foumet, B. Structures of O-glycosidically linked oligosaccharides isolated from human meconium glycoproteins. Eur. J. Biochem. 1989, 182, 139-152.
51. Itzkowitz, S. H.; Bloom, E. J.; Kokal, W. A.; Modin, G.; Hakomori, S.; Kim, Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990, 66, 1960-1966.
52. Matsushita, Y.; Cleary, K. R.; Ota, D. M.; Hoff, S. D.; Irimura, T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest. 1990, 63, 780-791.
53. Ogata, S.; Chen, A.; Itzkowitz, S. H. Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl- Tn antigen. Cancer Res. 1994, 54, 4036-4044.
54. Zhang, S.; Walberg, L. A.; Ogata, S.; Itzkowitz, S. H.; Koganty, R. R.; Reddish, M.; Gandhi, S. S.; Longenecker, B. M.; Lloyd, K. O.; Livingston, P. O. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res. 1995, 55, 3364-3368.
55. Bresalier, R. S.; Ho, S. B.; Schoeppner, H. L.; Kim, Y. S.; Sleisenger, M. H.; Bridt, P.; Byrd, J. C. Enhanced sialylation of mucin- associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996, 110, 1354-1367.
56. Robbe-Masselot, C.; Herrmann, A.; Carlstedt, I.; Michalski, J. C.; Capon, C. Glycosylation of the two O-glycosylated domains of MUC2 mucin in patients transposed with artificial urinary bladders constructed from proximal colonic tissue. Glycoconjugate J. 2008, 25, 213-224.
57. Saez, C.; lapon, M. A.; Poyeda, M. A.; Segura, D. I. Mucinous (colloid) adenocarcinomas secrete distinct O-acylated forms of sialomucins: a histochemical study of gastric, colorectal and breast adenocarcinomas. Histopathology 2001, 39, 554-560.
58. Harms, G.; Reuter, G.; Corfield, A. P.; Schauer, R. Binding specificity of influenza C-virus to variably O-acetylated glycoconjugates and its use for histochemical detection of N-acetyl-9-O-acetylneuraminic acid in mammalian tissues. Glycoconjugate J. 1996, 13, 621- 630.
59. Corfield, A. P.; Myerscough, N.; Warren, B. F.; Durdey, P.; Paraskeva, C.; Schauer, R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconjugate J. 1999, 16, 307-317.
60. Matsuda, K.; Masaki, T.; Watanabe, T.; Kitiyama, J.; Nagawa, H.; Muto, T.; Ajioka, Y. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn. J. Clin. Oncol 2000, 30, 89-94.
61. Manne, U.; Weiss, H. L.; Grizzle, W. E. Racial differences in the pronostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin. Cancer Res. 2000, 6, 4017-4025.
62. Bietmer-Huttmann, A. E.; Walsh, M. D.; McGuckin, M. A.; Simms, L. A.; Young, J.; Legget, B. A.; lass, R. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin. Cancer Res. 2000, 6, 1909-1916.
63. Hanisch, F. G.; Chai, W.; Rosankiewicz, J. R.; Lawson, A. M.; Stoll, M. S,; Feizi, T. Core-typing of O-linked glycans from human gastric mucins. Lack of evidence for the occurrence of the core sequence Gall-6GalNAc. Eur. J. Biochem. 1993, 15, 645-655. Erratum in Eur. J. Biochem. 1994, 1, 1087.
64. Irimura, T.; Wynn, D. M.; Hager, L. G.; Cleary, K. R.; Ota, D. M. Human colonic sulfomucin identified by a specific monoclonal antibody. Cancer Res. 1991, 51, 5728-5735.
65. Mann, B.; Klussmann, E.; Vandamme-Feldhaus, V.; Iwersen, M.; Hanski, M. L.; Riecken, E. O.; Buhr, H. J.; Schauer, R.; Kim, Y. S.; Hanski, C. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases. Int. J. Cancer 1997, 72, 258-264.
66. Takada, A.; Ohmori, K.; Yoneda, T.; Tsuyuoka, K.; Hasegawa, A.; Kiso, M.; Kannagi, R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993, 53, 354-361.
67. Kannagi, R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconjugate J. 1997, 14, 577-584.
68. Kawa, S.; Kato, M.; Oguchi, H.; Hsue, G. L.; Kobayashi, T.; Koiwai, T.; Tokoo, M.; Furuta, S.; Ichikawa, T.; Kanai, M. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA- 50, Spanl, Sialyl SSEA-1, and DUPAN-2. Scand. J. Gastroenterol. 1992, 27, 635-643.
69. Gullo, L. CA19-9: The Italian experience. Pancreas 1994, 9, 717-719.